Renal news roundup from AKF

In a recent letter, the American College of Cardiology, Society for Vascular Medicine and Society for Cardiovascular Angiography and Interventions urged the Cen...

Chronic kidney disease (CKD) affects 35 million adults in the United States, often going undetected until advanced stages. In this video, experts including Pran...

Maggie Goodman, a teacher, demonstrated remarkable selflessness by donating a kidney to her colleague Thomas Coveney, whom she barely knew. After learning of Co...

Fibroblast growth factor 23 (FGF23) is a promising biomarker for early detection of diabetic kidney disease (DKD), according to a study published in Diabetes, O...

A study in The Lancet indicates that GLP-1 drugs such as Ozempic could significantly benefit kidney transplant patients by reducing the risk of organ failure by...

The neutrophil-albumin ratio has emerged as a potential biomarker for identifying diabetic kidney disease. Research has shown that a higher neutrophil-albumin r...

Levels of serum fibroblast growth factor 23 (FGF23) can serve as an independent biomarker for early detection of diabetic kidney disease in patients with diabet...

A secondary analysis of the SCORED trial demonstrated that sotagliflozin reduced major adverse cardiovascular events (MACE), including myocardial infarction and...

A study in the Journal of Diabetes and its Complications highlights dapagliflozin's potential in preventing kidney damage caused by lipid overload. The res...